Cargando…
Clinical Outcomes of Patients with Metastatic Breast Cancer Treated with Hypo-Fractionated Liver Radiotherapy
SIMPLE SUMMARY: Local ablative liver radiotherapy is increasingly being used in the setting of metastatic disease, primarily to prevent local disease progression and potentially to improve patient survival. There is a paucity of data specifically reporting the role of liver-directed ablative radioth...
Autores principales: | Mushonga, Melinda, Helou, Joelle, Weiss, Jessica, Dawson, Laura A., Wong, Rebecca K. S., Hosni, Ali, Kim, John, Brierley, James, Koch, C. Anne, Alrabiah, Khalid, Lindsay, Patricia, Stanescu, Teo, Barry, Aisling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216793/ https://www.ncbi.nlm.nih.gov/pubmed/37345175 http://dx.doi.org/10.3390/cancers15102839 |
Ejemplares similares
-
Comparative Study of Hypo-Fractionated Radiotherapy Versus Conventional Radiotherapy in Breast Cancer
por: Narwariya, Abhinav, et al.
Publicado: (2022) -
Model-Supported Radiotherapy Personalization: In silico Test of Hyper- and Hypo-Fractionation Effects
por: Belfatto, Antonella, et al.
Publicado: (2018) -
Investigation of irradiated volume in linac-based brain hypo-fractionated stereotactic radiotherapy
por: Ruschin, Mark, et al.
Publicado: (2017) -
Neuro-ophthalmologic outcomes of standard versus hypo-fractionated stereotactic radiotherapy of AVPM
por: Zach, Leor, et al.
Publicado: (2021) -
A prospective randomized comparative study to evaluate the effect of palliative hypo-fractionated radiotherapy with concurrent chemotherapy versus hypo-fractionated radiotherapy alone in advanced and unresectable head and neck cancer with no metastasis
por: Uttam, Aditya Kumar, et al.
Publicado: (2023)